467 related articles for article (PubMed ID: 29796672)
1. Bidirectional regulation of adenosine-to-inosine (A-to-I) RNA editing by DEAH box helicase 9 (DHX9) in cancer.
Hong H; An O; Chan THM; Ng VHE; Kwok HS; Lin JS; Qi L; Han J; Tay DJT; Tang SJ; Yang H; Song Y; Bellido Molias F; Tenen DG; Chen L
Nucleic Acids Res; 2018 Sep; 46(15):7953-7969. PubMed ID: 29796672
[TBL] [Abstract][Full Text] [Related]
2. An I for an A: Dynamic Regulation of Adenosine Deamination-Mediated RNA Editing.
Vesely C; Jantsch MF
Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356042
[TBL] [Abstract][Full Text] [Related]
3. DHX9 suppresses RNA processing defects originating from the Alu invasion of the human genome.
Aktaş T; Avşar Ilık İ; Maticzka D; Bhardwaj V; Pessoa Rodrigues C; Mittler G; Manke T; Backofen R; Akhtar A
Nature; 2017 Apr; 544(7648):115-119. PubMed ID: 28355180
[TBL] [Abstract][Full Text] [Related]
4. An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer.
Qi L; Song Y; Chan THM; Yang H; Lin CH; Tay DJT; Hong H; Tang SJ; Tan KT; Huang XX; Lin JS; Ng VHE; Maury JJP; Tenen DG; Chen L
Nucleic Acids Res; 2017 Oct; 45(18):10436-10451. PubMed ID: 28985428
[TBL] [Abstract][Full Text] [Related]
5. Regulatory factors governing adenosine-to-inosine (A-to-I) RNA editing.
Hong H; Lin JS; Chen L
Biosci Rep; 2015 Mar; 35(2):. PubMed ID: 25662729
[TBL] [Abstract][Full Text] [Related]
6. To protect and modify double-stranded RNA - the critical roles of ADARs in development, immunity and oncogenesis.
Erdmann EA; Mahapatra A; Mukherjee P; Yang B; Hundley HA
Crit Rev Biochem Mol Biol; 2021 Feb; 56(1):54-87. PubMed ID: 33356612
[TBL] [Abstract][Full Text] [Related]
7. Noncoding regions of C. elegans mRNA undergo selective adenosine to inosine deamination and contain a small number of editing sites per transcript.
Wheeler EC; Washburn MC; Major F; Rusch DB; Hundley HA
RNA Biol; 2015; 12(2):162-74. PubMed ID: 25826568
[TBL] [Abstract][Full Text] [Related]
8. Induction of Viral Mimicry Upon Loss of DHX9 and ADAR1 in Breast Cancer Cells.
Cottrell KA; Ryu S; Pierce JR; Soto Torres L; Bohlin HE; Schab AM; Weber JD
Cancer Res Commun; 2024 Apr; 4(4):986-1003. PubMed ID: 38530197
[TBL] [Abstract][Full Text] [Related]
9. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2.
Ishiguro S; Galipon J; Ishii R; Suzuki Y; Kondo S; Okada-Hatakeyama M; Tomita M; Ui-Tei K
RNA Biol; 2018; 15(7):976-989. PubMed ID: 29950133
[TBL] [Abstract][Full Text] [Related]
10. Suppression of adenosine-to-inosine (A-to-I) RNA editome by death associated protein 3 (DAP3) promotes cancer progression.
Han J; An O; Hong H; Chan THM; Song Y; Shen H; Tang SJ; Lin JS; Ng VHE; Tay DJT; Molias FB; Pitcheshwar P; Tan HQ; Yang H; Chen L
Sci Adv; 2020 Jun; 6(25):eaba5136. PubMed ID: 32596459
[TBL] [Abstract][Full Text] [Related]
11. Adenosine Deaminases That Act on RNA (ADARs).
Wang Y; Zheng Y; Beal PA
Enzymes; 2017; 41():215-268. PubMed ID: 28601223
[TBL] [Abstract][Full Text] [Related]
12. ADARs and editing: The role of A-to-I RNA modification in cancer progression.
Fritzell K; Xu LD; Lagergren J; Öhman M
Semin Cell Dev Biol; 2018 Jul; 79():123-130. PubMed ID: 29146145
[TBL] [Abstract][Full Text] [Related]
13. irCLASH reveals RNA substrates recognized by human ADARs.
Song Y; Yang W; Fu Q; Wu L; Zhao X; Zhang Y; Zhang R
Nat Struct Mol Biol; 2020 Apr; 27(4):351-362. PubMed ID: 32203492
[TBL] [Abstract][Full Text] [Related]
14. Adenosine to inosine editing by ADAR2 requires formation of a ternary complex on the GluR-B R/G site.
Jaikaran DC; Collins CH; MacMillan AM
J Biol Chem; 2002 Oct; 277(40):37624-9. PubMed ID: 12163487
[TBL] [Abstract][Full Text] [Related]
15. Editor meets silencer: crosstalk between RNA editing and RNA interference.
Nishikura K
Nat Rev Mol Cell Biol; 2006 Dec; 7(12):919-31. PubMed ID: 17139332
[TBL] [Abstract][Full Text] [Related]
16. Nucleoside analog studies indicate mechanistic differences between RNA-editing adenosine deaminases.
Mizrahi RA; Phelps KJ; Ching AY; Beal PA
Nucleic Acids Res; 2012 Oct; 40(19):9825-35. PubMed ID: 22885375
[TBL] [Abstract][Full Text] [Related]
17. Editing independent effects of ADARs on the miRNA/siRNA pathways.
Heale BS; Keegan LP; McGurk L; Michlewski G; Brindle J; Stanton CM; Caceres JF; O'Connell MA
EMBO J; 2009 Oct; 28(20):3145-56. PubMed ID: 19713932
[TBL] [Abstract][Full Text] [Related]
18. ADARs, RNA editing and more in hematological malignancies.
Teoh PJ; Koh MY; Chng WJ
Leukemia; 2021 Feb; 35(2):346-359. PubMed ID: 33139858
[TBL] [Abstract][Full Text] [Related]
19. Proteome diversification by adenosine to inosine RNA editing.
Pullirsch D; Jantsch MF
RNA Biol; 2010; 7(2):205-12. PubMed ID: 20200492
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms and implications of ADAR-mediated RNA editing in cancer.
Wang C; Zou J; Ma X; Wang E; Peng G
Cancer Lett; 2017 Dec; 411():27-34. PubMed ID: 28974449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
